ELUT (Elutia) Net Interest Margin (Bank Only) %


ELUT Elutia Inc ELUT
37 GF Score
Price $0.96
GF Value $0.91
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Elutia Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

ELUT
37GF Score
Elutia Inc ELUT
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Elutia (ELUT) Overvalued in 2026?

Based on GuruFocus' analysis, Elutia stock appears to be overvalued. The current stock price of $0.96 is trading 5.1% above its estimated GF Value™ of $0.91. GuruFocus considers Elutia to be Fairly Valued.

Key valuation signals for ELUT:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: $0.91 vs. price of $0.96 (5.1% above fair value)
  • GF Score™: 37/100 with 5 warning signs

No single metric tells the full story. See the ELUT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Elutia Business Description

Address 20 Firstfield Road, Gaithersburg, MD, USA, 20878
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.
37GF Score

Get the complete analysis for ELUT

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.96
Price
$0.91
GF Value